![Kabir Kumar Nath](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kabir Kumar Nath
Vorstandsvorsitzender bei COMPASS PATHWAYS PLC
Vermögen: 72 678 $ am 31.05.2024
Profil
Kabir Kumar Nath is currently the Chief Executive Officer & Director at Compass Pathways Plc since 2022.
He is also currently serving as the Director at Otsuka Canada Pharmaceutical, Inc. since 2018.
Previously, he held positions such as President & Chief Executive Officer at Otsuka America Pharmaceutical, Inc., Director & Head-North America Pharmaceutical at Otsuka Pharmaceutical Co., Ltd., Director at ZymoGenetics, Inc., Director at Inhibitex LLC, and President Commissioner at PT Taisho Pharmaceutical Indonesia.
Mr. Nath holds an MBA from INSEAD and a graduate degree from King's College, Cambridge.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
COMPASS PATHWAYS PLC
0,03% | 27.03.2024 | 9 848 ( 0,03% ) | 72 678 $ | 31.05.2024 |
Aktive Positionen von Kabir Kumar Nath
Unternehmen | Position | Beginn |
---|---|---|
COMPASS PATHWAYS PLC | Vorstandsvorsitzender | 01.08.2022 |
Otsuka Canada Pharmaceutical, Inc.
![]() Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Canada Pharmaceutical, Inc. is a Canadian healthcare company that commercializes Otsuka medicines in Canada, with a focus on neuroscience and nephrology. The company is based in Saint-Laurent, Canada and was founded in 1921. The company is dedicated to improving patients' health and the quality of human life. Otsuka Pharmaceutical Co., Ltd., the parent company, is a healthcare company with the corporate philosophy of creating new products for better health worldwide. | Direktor/Vorstandsmitglied | 23.03.2018 |
Ehemalige bekannte Positionen von Kabir Kumar Nath
Unternehmen | Position | Ende |
---|---|---|
TAISHO PHARMACEUTICAL INDONESIA TBK PT | Vorsitzender | - |
Otsuka America Pharmaceutical, Inc.
![]() Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Vorstandsvorsitzender | - |
ZymoGenetics, Inc.
![]() ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | - |
Inhibitex LLC
![]() Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Direktor/Vorstandsmitglied | - |
Otsuka Pharmaceutical Co., Ltd.
![]() Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Co. Ltd. engages in the manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. Its operations are carried out through the following business divisions: Pharmaceutical Business and Nutraceutical Business. The Pharmaceutical Business division engages in the manufacture and sale of pharmaceutical products for the diagnosis and treatment of diseases. The Nutraceutical Business division provides nutritional products, cosmetics and medicines that support day-to-day health maintenance and improvement. The company was founded on August 10, 1964 and is headquartered in Tokyo, Japan. | Direktor/Vorstandsmitglied | - |
Ausbildung von Kabir Kumar Nath
INSEAD | Masters Business Admin |
King's College, Cambridge | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
COMPASS PATHWAYS PLC | Health Technology |
Private Unternehmen | 6 |
---|---|
Otsuka Pharmaceutical Co., Ltd.
![]() Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Co. Ltd. engages in the manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. Its operations are carried out through the following business divisions: Pharmaceutical Business and Nutraceutical Business. The Pharmaceutical Business division engages in the manufacture and sale of pharmaceutical products for the diagnosis and treatment of diseases. The Nutraceutical Business division provides nutritional products, cosmetics and medicines that support day-to-day health maintenance and improvement. The company was founded on August 10, 1964 and is headquartered in Tokyo, Japan. | Health Technology |
ZymoGenetics, Inc.
![]() ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Inhibitex LLC
![]() Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Health Technology |
Otsuka America Pharmaceutical, Inc.
![]() Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
PT Taisho Pharmaceutical Indonesia
![]() PT Taisho Pharmaceutical Indonesia Pharmaceuticals: MajorHealth Technology PT Taisho Pharmaceutical Indonesia engages in the development, registration, process, production and sale of chemical, pharmaceutical, and health care products. Its products include Tempra, Analgesic Balm and Theragran-M. The company was founded on July 8, 1970 and is headquartered in Jakarta, Indonesia. | Health Technology |
Otsuka Canada Pharmaceutical, Inc.
![]() Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Canada Pharmaceutical, Inc. is a Canadian healthcare company that commercializes Otsuka medicines in Canada, with a focus on neuroscience and nephrology. The company is based in Saint-Laurent, Canada and was founded in 1921. The company is dedicated to improving patients' health and the quality of human life. Otsuka Pharmaceutical Co., Ltd., the parent company, is a healthcare company with the corporate philosophy of creating new products for better health worldwide. | Health Technology |